[A clinical study of pathophysiological feature of "Bartter's syndrome" (author's transl)].
D000328:Adult; D000804:Angiotensin II; D001241:Aspirin / Q000627:therapeutic use; D001477:Bartter Syndrome / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004039:Diet, Sodium-Restricted; D004573:Electrolytes / Q000097:blood; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology*; D007008:Hypokalemia / Q000150:complications; D007052:Ibuprofen / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007223:Infant; D008297:Male; D012083:Renin / Q000097:blood; D014882:Water-Electrolyte Balance
D004573:Electrolytes; D000804:Angiotensin II; D012083:Renin; D001241:Aspirin; D007052:Ibuprofen; D007213:Indomethacin